Immuno-Cell International SRL

6.5 FTE

Immuno-Cell International reported total assets of €1.56m at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jun 2026), with 6.5 full-time equivalents.

By total assets for 2025, Immuno-Cell International ranks among the 200 largest of the 789 companies in its sector (NACE 1812) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0453.361.865 · VAT BE0453361865
2800 Mechelen
active in Other printing (NACE 18120)
operating since 01 Aug 1994 (≈ 32 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Immuno-Cell International shows with a free account.

See the score
Profile
SRL Micro · 6.5 FTE since 1994
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result478,283 €
Equity955,309 €
Cash191,362 €
EBITDA730,792 €
Total assets€1.56m
Headcount (avg FTE)6.5
The line marks its sector median: 45.9% (491 companies).

Change 2022 → 2025: Equity +101 % Total assets -30 % Headcount (avg FTE) +18 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Immuno-Cell International's annual accounts

20252024202320222021
Net result478,283 €
Equity955,309 €
Cash191,362 €
EBITDA730,792 €
Total assets€1.56m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 08 Jun 2026
  • Year ended 31 Dec 2024filed on 29 Aug 2025
  • Year ended 31 Dec 2023filed on 30 Jul 2024
  • Year ended 31 Dec 2022filed on 31 Jul 2023
  • Year ended 31 Dec 2021filed on 16 Aug 2022

Immuno-Cell International's financial analysis

Management and control of Immuno-Cell International

2 active director(s) in the register.

Immuno-Cell International's shareholders and holdings →

Immuno-Cell International's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0453.361.865
VAT number
BE0453361865
Peppol
Registered · 0208:0453361865 · as of 10 Nov 2026
Legal form
SRL
Incorporated
01 Aug 1994
Registered office
2800 Mechelen
Size
Micro · 6.5 FTE
Latest accounts
2025 · filed on 08 Jun 2026
Activity
Other printing (NACE 18120)

Immuno-Cell International (SRL) has been based in Mechelen since 1994, active in: other printing. For 2025, it reports a net profit of 478,283 € and equity of 955,309 €; its revenue is not published. With 6.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 61.3%, above the median of its sector (45.9%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Immuno-Cell International

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Immuno-Cell International

What is the revenue of Immuno-Cell International?

Immuno-Cell International files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Immuno-Cell International?

In Belgium, the VAT number is the company number prefixed with BE: BE0453361865 for Immuno-Cell International, if the company is VAT-registered. Its company number (CBE) is 0453.361.865.

Where is the registered office of Immuno-Cell International?

According to the CBE register, the registered office of Immuno-Cell International is in 2800 Mechelen.

What is the equity of Immuno-Cell International?

At the close of the 2025 financial year, the equity of Immuno-Cell International amounts to 955,309 €, a solvency of 61.3% of total assets.

How many people work at Immuno-Cell International?

6.5 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Immuno-Cell International?

The register lists 2 active mandates at Immuno-Cell International. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Immuno-Cell International within its sector?

By total assets for 2025, Immuno-Cell International ranks among the 200 largest of the 789 companies in its sector (NACE 1812) in Belgium that filed accounts for that financial year.

Idonis

The full file of Immuno-Cell International

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 08 Jul 2026

No credit card, no commitment.

What each plan unlocks →